Skip to content

Insertion of a Transoesophageal Echocardiography Probe Using McGRATH

Insertion of a Transoesophageal Echocardiography Probe Using McGRATH Video Laryngoscope in Cardiac Surgery Patients: Randomized Controlled Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07346898
Enrollment
100
Registered
2026-01-16
Start date
2026-01-01
Completion date
2026-06-30
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Echocardiography, Transesophageal

Keywords

cardiac anaesthesia, Transesophageal Echocardiography, pharyngeal mucosal injury

Brief summary

This randomized, parallel-group clinical trial compares McGRATH video laryngoscope-assisted versus Macintosh laryngoscope-assisted transoesophageal echocardiography (TEE) probe insertion in adult elective cardiac surgery patients. The primary aim is to compare incidence of pharyngeal mucosal injury during TEE probe insertion.

Detailed description

Transoesophageal echocardiography (TEE) is essential in cardiac anesthesia but TEE probe insertion can cause oropharyngeal mucosal injury and, rarely, esophageal perforation. In this prospective randomized study, adults (≥18 years, ASA II-III) undergoing elective cardiac surgery requiring intraoperative TEE will be randomized 1:1 to TEE probe insertion assisted by either the McGRATH MAC video laryngoscope (M group) or a conventional Macintosh laryngoscope (C group). After induction and tracheal intubation, TEE probe insertion will be attempted with the head in neutral position; the esophageal inlet visibility, number of attempts, total insertion time (seconds), intraoperative vital signs during insertion, and anesthesiologist satisfaction will be recorded. A blinded observer will assess pharyngeal mucosal injury (laceration and/or hematoma) immediately after probe removal. Sample size: 100 (50 per arm). An interim safety analysis will occur after 50 patients; a DSMB will review safety.

Interventions

DEVICEMcGRATH group

McGRATH video laryngoscope used to assist TEE probe insertion in an intubated patient under general anesthesia

Macintosh laryngoscope used to assist TEE probe insertion in an intubated patient under general anesthesia

Sponsors

Cairo University
Lead SponsorOTHER
Prince Sultan Cardiac Center, Adult Cardiology Department.
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Prospective, randomized controlled study This is a Parallel-Group Randomized Controlled Trial (RCT) - each participant is randomized into one of two groups, receives only that intervention, and outcomes are compared between groups. There's no crossover, no sequential intervention; both groups proceed in parallel. Number of study arms: There are two arms: Macintosh group (C group) - TEE probe insertion assisted by a conventional Macintosh laryngoscope. McGRATH group (M group) - TEE probe insertion assisted by a McGRATH video laryngoscope. Each arm receives a distinct intervention, and the primary endpoint (incidence of pharyngeal mucosal injury) will be compared between them.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (male or female) aged ≥ 18 years * ASA physical status II or III * Scheduled for elective cardiac surgery under general anesthesia requiring intraoperative transoesophageal echocardiography * Able to provide written informed consent

Exclusion criteria

* Dysphagia or sore throat * Oropharyngeal infection * Cervical spine pathology

Design outcomes

Primary

MeasureTime frameDescription
Incidence of pharyngeal mucosal injuryImmediately after TEE probe removal (intraoperatively)Presence of laceration and/or hematoma in the posterior pharyngeal wall, postcricoid area, lateral/medial walls of the piriform sinuses, or the esophageal inlet as observed by a blinded observer after removal of the TEE probe.

Secondary

MeasureTime frameDescription
Visibility of the oesophageal inletDuring TEE probe insertion (first insertion attempt, intraoperatively)Categorical - "Visible" vs "Not visible" as recorded by the operator.
Duration of TEE probe insertion (seconds)During the intraoperative TEE probe insertion procedureTotal duration in seconds from mouth opening to successful esophageal insertion, summed across all insertion attempts.
Number of insertion attemptsDuring the intraoperative TEE probe insertion procedureCount of discrete insertions into the mouth until successful esophageal passage or study-defined stop

Countries

Saudi Arabia

Contacts

CONTACTAhmed Abdalwahab, MD
aabdalwahab@pscc.med.sa00966533437590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026